MedTrace Logo

Pulsed Electromagnetic Field Treatment for Painful Periods

NCT03394547 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-06-13

No results posted yet for this study

Summary

A single-centre, randomised controlled, double blind study comparing use of the Allay pulsed shortwave therapy treatment versus a placebo device or no treatment for management of primary dysmenorrhea.

Conditions

  • Dysmenorrhea

Interventions

DEVICE

Allay

pulsed shortwave therapy treatment for painful periods

DEVICE

Placebo

A placebo device is given which is identical to the Allay device but emits no pulsed shortwave therapy.

Sponsors & Collaborators

  • BioElectronics Corporation

    collaborator INDUSTRY

  • Birmingham Women's NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Justin Clark · Birmingham Women's NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-03
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394547 on ClinicalTrials.gov